Yu Oyama

2.3k total citations
44 papers, 1.5k citations indexed

About

Yu Oyama is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Yu Oyama has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 17 papers in Pathology and Forensic Medicine and 11 papers in Oncology. Recurrent topics in Yu Oyama's work include Hematopoietic Stem Cell Transplantation (17 papers), Systemic Sclerosis and Related Diseases (12 papers) and Inflammatory Bowel Disease (5 papers). Yu Oyama is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Systemic Sclerosis and Related Diseases (12 papers) and Inflammatory Bowel Disease (5 papers). Yu Oyama collaborates with scholars based in United States, Japan and Italy. Yu Oyama's co-authors include Richard K. Burt, Ann Traynor, Larissa Verda, Robert M. Craig, Laisvyde Statkute, Kathleen Quigley, Bruce A. Cohen, Francesca Milanetti, Mary Brush and Amy L. Halverson and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Gastroenterology.

In The Last Decade

Yu Oyama

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Oyama United States 19 483 459 398 352 331 44 1.5k
Ann Traynor United States 26 647 1.3× 680 1.5× 582 1.5× 381 1.1× 298 0.9× 63 2.1k
Majid Kazmi United Kingdom 19 454 0.9× 568 1.2× 279 0.7× 234 0.7× 115 0.3× 39 1.4k
Kathleen Quigley United States 16 379 0.8× 282 0.6× 249 0.6× 213 0.6× 210 0.6× 22 976
Charles D. Bangs United States 19 247 0.5× 177 0.4× 328 0.8× 228 0.6× 157 0.5× 44 1.6k
Odilia B. J. Corneth Netherlands 22 281 0.6× 155 0.3× 797 2.0× 374 1.1× 120 0.4× 46 1.5k
Juehua Gao United States 16 321 0.7× 197 0.4× 233 0.6× 269 0.8× 122 0.4× 60 1.1k
Gyeongsin Park South Korea 18 308 0.6× 265 0.6× 267 0.7× 238 0.7× 61 0.2× 80 1.1k
Marie Parrens France 25 1.3k 2.7× 248 0.5× 549 1.4× 553 1.6× 73 0.2× 95 2.5k
Amit Nathwani United Kingdom 24 204 0.4× 246 0.5× 311 0.8× 429 1.2× 217 0.7× 67 1.5k
François Cornélis France 29 197 0.4× 137 0.3× 685 1.7× 138 0.4× 311 0.9× 62 1.8k

Countries citing papers authored by Yu Oyama

Since Specialization
Citations

This map shows the geographic impact of Yu Oyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Oyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Oyama more than expected).

Fields of papers citing papers by Yu Oyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Oyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Oyama. The network helps show where Yu Oyama may publish in the future.

Co-authorship network of co-authors of Yu Oyama

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Oyama. A scholar is included among the top collaborators of Yu Oyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Oyama. Yu Oyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oyama, Yu, Akira Honda, Yosuke Masamoto, et al.. (2021). Severe cellulitis caused by Achromobacter xylosoxidans after allogeneic hematopoietic stem cell transplantation. Journal of Infection and Chemotherapy. 27(5). 770–772. 1 indexed citations
3.
Burt, Richard K., Robert M. Craig, Francesca Milanetti, et al.. (2010). Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood. 116(26). 6123–6132. 125 indexed citations
4.
Burt, Richard K., Alessandro Testori, Yu Oyama, et al.. (2009). Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplantation. 45(1). 111–116. 66 indexed citations
5.
Burt, Richard K., Yvonne Loh, Bruce A. Cohen, et al.. (2009). Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. The Lancet Neurology. 8(3). 244–253. 198 indexed citations
6.
7.
Oyama, Yu, Walter G. Barr, Laisvyde Statkute, et al.. (2007). Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis. Bone Marrow Transplantation. 40(6). 549–555. 62 indexed citations
8.
Statkute, Laisvyde, Larissa Verda, Yu Oyama, et al.. (2007). Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplantation. 39(6). 317–329. 35 indexed citations
9.
Verda, Larissa, Kui Luo, Adam P. Kohm, et al.. (2006). Effect of hematopoietic growth factors on severity of experimental autoimmune encephalomyelitis. Bone Marrow Transplantation. 38(6). 453–460. 9 indexed citations
10.
Oyama, Yu, Robert M. Craig, Ann Traynor, et al.. (2005). Autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s disease. Gastroenterology. 128(3). 552–563. 193 indexed citations
11.
Burt, Richard K., Yu Oyama, Larissa Verda, et al.. (2004). Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis & Rheumatism. 50(8). 2466–2470. 62 indexed citations
12.
Burt, Richard K., William R. Drobyski, Tatiana Seregina, et al.. (2003). Herpes simplex thymidine kinase gene–transduced donor lymphocyte infusions. Experimental Hematology. 31(10). 903–910. 36 indexed citations
13.
Oyama, Yu, Joan Guitart, Timothy M. Kuzel, Richard K. Burt, & Steven T. Rosen. (2003). High-dose therapy and bone marrow transplantation in cutaneous T-cell lymphoma. Hematology/Oncology Clinics of North America. 17(6). 1475–1483. 16 indexed citations
14.
Burt, Richard K., Kui Luo, Yu Oyama, et al.. (2003). Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease. Bone Marrow Transplantation. 32(S1). S29–S31. 15 indexed citations
15.
Oyama, Yu, Jane N. Winter, Martin S. Tallman, et al.. (2003). Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?. Bone Marrow Transplantation. 31(10). 861–864. 16 indexed citations
16.
Oyama, Yu, Ann Traynor, Walter G. Barr, & Richard K. Burt. (2003). Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens. Bone Marrow Transplantation. 32(S1). S81–S83. 14 indexed citations
17.
Burt, Richard K., Yu Oyama, Ann Traynor, et al.. (2003). Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring?. Bone Marrow Transplantation. 32(S1). S65–S67. 14 indexed citations
18.
Craig, Robert M., Ann Traynor, Yu Oyama, & Richard K. Burt. (2003). Hematopoietic stem cell transplantation for severe Crohn's disease. Bone Marrow Transplantation. 32(S1). S57–S59. 33 indexed citations
19.
Guitart, Joan, Yu Oyama, Timothy M. Kuzel, et al.. (2002). Long-term Remission After Allogeneic Hematopoietic Stem Cell Transplantation for Refractory Cutaneous T-Cell Lymphoma. Archives of Dermatology. 138(10). 1359–65. 46 indexed citations
20.
Oyama, Yu, et al.. (2001). Allogeneic stem cell transplantation for Evans syndrome. Bone Marrow Transplantation. 28(9). 903–905. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026